(Q43897047)

27 November 2017

Influence of food intake and formulation on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist (English)

1 reference

27 November 2017

1 reference

Jasper Dingemanse

1

1 reference

27 November 2017

Frederic Bodin

2

1 reference

27 November 2017

Erhard Weidekamm

3

1 reference

27 November 2017

Klaus Kutz

4

1 reference

27 November 2017

Paul van Giersbergen

5

1 reference

27 November 2017

1 March 2002

1 reference

The Journal of Clinical Pharmacology

27 November 2017

1 reference

27 November 2017

42

1 reference

27 November 2017

3

1 reference

27 November 2017

283-289

1 reference

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

27 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Endothelin-receptor antagonists: current and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Effects of food on clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

?ndothelin: new discoveries and rapid progress in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

The endothelin family of peptides: local hormones with diverse roles in health and disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Determination of an endothelin receptor antagonist in human plasma by narrow-bore liquid chromatography and ionspray tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011300

10.1177/00912700222011300

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference